European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f
Dr. ZhiChao Dang appointed honorary professor in China Dr. ZhiChao Dang of the National Institute of Public Health and Environment (RIVM) was appointed honorary professor at the highly renowned Nanjing Institute of Environmental Sciences (NIES).
The National Immunisation Programme in the Netherlands 2013 - 2014 Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).
Point-of-care testing in nursing homes in the Netherlands RIVM has conducted an explorative study on the use of point-of-care (POC) tests in nursing homes.
Personalised medicine provides optimal treatment In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach
Citizen science network produces accurate maps of fine air particles Measurements by thousands of citizen scientists in the Netherlands using their smartphones and the iSPEX add-on are delivering accurate data on fine air particles in the atmosphere that add valuabl
Sustainability of EU regulatory system on medicinal products In safeguarding the quality, safety and efficacy of medicinal products, the present EU regulatory system has become a time consuming and highly regulated process.
Information about medicines more accessible to the user The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w
Average disease burden highest for invasive pneumococcal disease and influenza The average annual disease burden for the total Dutch population was highest for invasive pneumococcal disease and influenza.